伙伴
发表于 2025-3-23 10:14:10
http://reply.papertrans.cn/17/1650/164936/164936_11.png
Hiatus
发表于 2025-3-23 16:23:48
http://reply.papertrans.cn/17/1650/164936/164936_12.png
连词
发表于 2025-3-23 20:18:30
Jochen Ludewig,Martin Glinz,Hans Matheiso a number of quite fundamental aspects of their antipsychotic actions, including such basic issues as diagnostic specificity, time-course of therapeutic effect, optimal dosage and most effective treatment strategy.
anniversary
发表于 2025-3-23 23:15:50
http://reply.papertrans.cn/17/1650/164936/164936_14.png
公猪
发表于 2025-3-24 03:37:20
http://reply.papertrans.cn/17/1650/164936/164936_15.png
Gum-Disease
发表于 2025-3-24 08:52:00
Zenia Pérez-Falls,Guillermo Martínez-Floress [.–.]. We are currently nearing the end of this era now that several SDAs (serotonin dopamine antagonists) have been discovered and marketed, with a few more in the late stages of clinical development. These compounds have been discussed and emphasised in many of the preceding chapters of this book.
correspondent
发表于 2025-3-24 11:00:20
http://reply.papertrans.cn/17/1650/164936/164936_17.png
Immunoglobulin
发表于 2025-3-24 18:44:06
Simulation models for schizophreniauate the effects of (atypical) antipsychotic drugs. This chapter will therefore predominantly focus on the various models that have been developed and only describe the effects of (atypical) antipsychotics when rigorous screening has been performed.
竖琴
发表于 2025-3-24 22:19:22
Dopamine receptor subtypes and schizophrenia: a clinical perspectiveypes of DA-receptors, or by decreasing metabolism or other aspects of neurotransmission of cerebral DA-containing neurons. These pharmacological properties led to the proposal of an increased DA-activity in the limbic system in schizophrenia [.-.].
BAIT
发表于 2025-3-24 23:56:56
http://reply.papertrans.cn/17/1650/164936/164936_20.png